Inovio Pharmaceuticals Inc. closed $12.82 below its 52-week high ($14.75), which the company achieved on April 1st.
Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.
The company priced a public offering of 10 million shares of common stock and accompanying warrants. Discover Fast-Growing Stocks Every Month Inovio Pharmaceuticals Inc INO shares are trading ...
Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, with retail sentiment staying bullish ...
Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...
State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...
Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...
In terms of launching INO-3107, Shea and others chose their words ... the title comes from the prospect of potential gain if the stock recovers or snaps back. I do not expect Inovio to experience ...